Home › Foundation Medicine Q3 Revenues Rise 16 Percent, Net Loss Widens

Foundation Medicine Q3 Revenues Rise 16 Percent, Net Loss Widens

Nov 02, 2016

This article has been updated with information and comments from Foundation Medicine's earnings conference call.

NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Wednesday that third quarter revenues rose 16 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

What's Popular?

In Cancer

  1. NeoGenomics Reports 5 Percent Rise in Q2 Revenues

  2. Roche Receives CE Mark for NSCLC Drug CDx

  3. OncoDNA, Everything Genetic Sign Distribution Deal

  4. Bio-Rad Gets FDA Clearance, CE Marking for Updated Tumor Marker Control

  5. Christiana Care, NovellusDx Ink Licensing Deal for Gene-Editing Tech

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.